Product information
From Health Canada
Current status:
Marketed
Current status date:
2006-07-22
Original market date: See footnote 1
1991-12-31
Product name:
SODIUM PHOSPHATES INJECTION USP
DIN:
00896187 Electronic product monograph is not available
Company:
SANDOZ CANADA INCORPORATED
110 Rue De Lauzon
Boucherville
Quebec
Canada
J4B 1E6
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
2
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
40:12.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
B05XA09 SODIUM PHOSPHATE
Active ingredient group (AIG) number:See footnote5
0208589002
Active ingredient(s) | Strength |
---|---|
SODIUM PHOSPHATE DIBASIC | 268 MG / ML |
SODIUM PHOSPHATE MONOBASIC | 276 MG / ML |